Table 3.
Overall Survival in the Two Groups
| CG group | PC group | |
|---|---|---|
| (n=253) | (n=68) | |
| Median survival time, months | 9.6 | 9 | 
| 1-year survival | 38 | 33 | 
| 2-year survival | 16 | 17 | 
| 3-year survival | 8 | 6 | 
| 4-year survival | 2 | 2 | 
| 5-year survival | 0 | 0 | 
CG, carboplatin + gemcitabine; PC, paclitaxel + carboplatin